JP2012506411A5 - - Google Patents

Download PDF

Info

Publication number
JP2012506411A5
JP2012506411A5 JP2011532725A JP2011532725A JP2012506411A5 JP 2012506411 A5 JP2012506411 A5 JP 2012506411A5 JP 2011532725 A JP2011532725 A JP 2011532725A JP 2011532725 A JP2011532725 A JP 2011532725A JP 2012506411 A5 JP2012506411 A5 JP 2012506411A5
Authority
JP
Japan
Prior art keywords
factor
binding protein
immune response
composition according
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011532725A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012506411A (ja
JP5676458B2 (ja
Filing date
Publication date
Priority claimed from GBGB0819633.9A external-priority patent/GB0819633D0/en
Application filed filed Critical
Publication of JP2012506411A publication Critical patent/JP2012506411A/ja
Publication of JP2012506411A5 publication Critical patent/JP2012506411A5/ja
Application granted granted Critical
Publication of JP5676458B2 publication Critical patent/JP5676458B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011532725A 2008-10-25 2009-10-26 変異h因子結合タンパク質を含むワクチン組成物 Expired - Fee Related JP5676458B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0819633.9 2008-10-25
GBGB0819633.9A GB0819633D0 (en) 2008-10-25 2008-10-25 Composition
PCT/GB2009/051439 WO2010046715A1 (en) 2008-10-25 2009-10-26 Vaccine compositions comprising a mutated factor h binding protein

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014261910A Division JP6076326B2 (ja) 2008-10-25 2014-12-25 変異h因子結合タンパク質を含むワクチン組成物

Publications (3)

Publication Number Publication Date
JP2012506411A JP2012506411A (ja) 2012-03-15
JP2012506411A5 true JP2012506411A5 (https=) 2012-12-06
JP5676458B2 JP5676458B2 (ja) 2015-02-25

Family

ID=40133849

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011532725A Expired - Fee Related JP5676458B2 (ja) 2008-10-25 2009-10-26 変異h因子結合タンパク質を含むワクチン組成物
JP2014261910A Expired - Fee Related JP6076326B2 (ja) 2008-10-25 2014-12-25 変異h因子結合タンパク質を含むワクチン組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014261910A Expired - Fee Related JP6076326B2 (ja) 2008-10-25 2014-12-25 変異h因子結合タンパク質を含むワクチン組成物

Country Status (23)

Country Link
US (1) US20120052092A1 (https=)
EP (2) EP3501534B1 (https=)
JP (2) JP5676458B2 (https=)
KR (3) KR20190011836A (https=)
CN (2) CN105412920A (https=)
AU (1) AU2009306114B2 (https=)
BR (1) BRPI0919926A2 (https=)
CA (1) CA2741619A1 (https=)
CO (1) CO6382140A2 (https=)
DK (1) DK3501534T5 (https=)
ES (1) ES2970878T3 (https=)
FI (1) FI3501534T3 (https=)
GB (1) GB0819633D0 (https=)
HR (1) HRP20240226T1 (https=)
HU (1) HUE065348T2 (https=)
LT (1) LT3501534T (https=)
MX (1) MX2011004322A (https=)
NZ (2) NZ601538A (https=)
PL (1) PL3501534T3 (https=)
PT (1) PT3501534T (https=)
RU (1) RU2559528C2 (https=)
SI (1) SI3501534T1 (https=)
WO (1) WO2010046715A1 (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2261352A3 (en) 1998-05-01 2012-01-04 Novartis Vaccines and Diagnostics, Inc. Neisseria meningitidis antigens and compositions
EP2270173B1 (en) 1999-05-19 2016-01-06 GlaxoSmithKline Biologicals SA Combination neisserial compositions
RU2281956C2 (ru) 1999-10-29 2006-08-20 Чирон С.Р.Л. Антигенные пептиды neisseria
ES2281409T3 (es) 2000-02-28 2007-10-01 Novartis Vaccines And Diagnostics S.R.L. Expresion heterologa de proteinas de neisseria.
GB0118249D0 (en) 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
GB0121591D0 (en) 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
HUE031886T2 (en) 2002-10-11 2017-08-28 Glaxosmithkline Biologicals Sa Polypeptide vaccines for extensive protection against hypervirulent meningococcal lines
GB0227346D0 (en) 2002-11-22 2002-12-31 Chiron Spa 741
GB0408977D0 (en) 2004-04-22 2004-05-26 Chiron Srl Immunising against meningococcal serogroup Y using proteins
GB0524066D0 (en) 2005-11-25 2006-01-04 Chiron Srl 741 ii
CN102356089B (zh) 2008-02-21 2014-02-19 诺华股份有限公司 脑膜炎球菌fHBP多肽
ES2557282T3 (es) 2008-03-10 2016-01-25 Children's Hospital & Research Center At Oakland Proteínas quiméricas de unión al factor H (fHBP) que contienen un dominio B heterólogo, y métodos de uso
HUE049695T2 (hu) 2009-03-24 2020-10-28 Glaxosmithkline Biologicals Sa Adjuváló H meningococcus faktort kötõ fehérje
CA2759400A1 (en) 2009-04-30 2010-11-04 Children's Hospital & Research Center At Oakland Chimeric factor h binding proteins (fhbp) and methods of use
CA2779816A1 (en) * 2009-10-27 2011-05-05 Novartis Ag Modified meningococcal fhbp polypeptides
EP2544714A1 (en) * 2010-03-10 2013-01-16 GlaxoSmithKline Biologicals S.A. Vaccine composition
ES2910199T3 (es) 2010-03-30 2022-05-11 Childrens Hospital & Res Center At Oakland Proteínas de unión al factor H (fHbp) con propiedades alteradas y métodos de uso de las mismas
CA2803239A1 (en) 2010-06-25 2011-12-29 Novartis Ag Combinations of meningococcal factor h binding proteins
JP5957541B2 (ja) 2012-02-02 2016-07-27 ノバルティス アーゲー 髄膜炎菌における増加したタンパク質発現のためのプロモータ
MX357538B (es) 2012-06-14 2018-07-13 Novartis Ag Vacunas para meningococo de serogrupo x.
AU2013295242C1 (en) 2012-07-27 2018-08-09 Institut National De La Sante Et De La Recherche Medicale CD147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia
US20160030544A1 (en) * 2013-03-14 2016-02-04 Isis Innovation Limited Immunogenic composition to neisseria
EA201690056A8 (ru) 2013-08-02 2017-07-31 Чилдренс Хоспитл Энд Рисерч Сентер Эт Окленд ИСКУССТВЕННЫЕ БЕЛКИ, СВЯЗЫВАЮЩИЕ ФАКТОР Н (fHbp), И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
JP6786394B2 (ja) 2014-02-28 2020-11-18 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 改変髄膜炎菌fHbpポリペプチド
CA3212723A1 (en) 2014-07-23 2016-01-28 Peter T. Beernink Factor h binding protein variants and methods of use thereof
MX378112B (es) * 2014-08-20 2025-03-10 Stichting Sanquin Bloedvoorziening Anticuerpos que potencian el factor h y sus usos.
GB201614687D0 (en) * 2016-08-31 2016-10-12 Univ Oxford Innovation Ltd fHbp scaffold
EP3607967A1 (en) 2018-08-09 2020-02-12 GlaxoSmithKline Biologicals S.A. Modified meningococcal fhbp polypeptides
AU2019410099A1 (en) 2018-12-21 2021-07-15 Griffith University Compositions, methods and uses for eliciting an immune response
WO2021007365A1 (en) * 2019-07-08 2021-01-14 Crapaud Bio, Inc. Methods of making and using lipooligosaccharide compositions and vaccines
AR122286A1 (es) 2019-07-17 2022-08-31 Gemini Therapeutics Sub Inc Anticuerpos potenciadores del factor h y usos de estos
US12053516B2 (en) 2021-02-19 2024-08-06 Sanofi Pasteur Inc. Meningococcal B recombinant vaccine
TW202423477A (zh) 2022-08-03 2024-06-16 美商賽諾菲巴斯德公司 針對腦膜炎奈瑟氏菌b的含佐劑免疫原性組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786592A (en) * 1986-06-18 1988-11-22 Scripps Clinic And Research Foundation Neisseria gonorrhoeae lectin useful as a vaccine and diagnostic marker and means for producing this lectin
US5476784A (en) * 1993-04-06 1995-12-19 Rice; Peter A. Gonococcal anti-idiotypic antibodies and methods and compositions using them
GB0220194D0 (en) * 2002-08-30 2002-10-09 Chiron Spa Improved vesicles
MXPA05011110A (es) * 2003-04-16 2006-01-24 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de un padecimiento originado por meningococos.
ES2616294T3 (es) * 2005-01-27 2017-06-12 Children's Hospital & Research Center At Oakland Vacunas de vesículas basadas en GNA1870 para protección de amplio espectro contra enfermedades provocadas por Neisseria meningitidis
GB0524066D0 (en) * 2005-11-25 2006-01-04 Chiron Srl 741 ii
CA2656474A1 (en) * 2006-06-29 2008-01-03 Novartis Ag Polypeptides from neisseria meningitidis
US20110076300A1 (en) * 2009-08-27 2011-03-31 Mariagrazia Pizza Hybrid Polypeptides Including Meningococcal fHBP Sequences
ES2910199T3 (es) * 2010-03-30 2022-05-11 Childrens Hospital & Res Center At Oakland Proteínas de unión al factor H (fHbp) con propiedades alteradas y métodos de uso de las mismas

Similar Documents

Publication Publication Date Title
JP2012506411A5 (https=)
RU2011120706A (ru) Композиции вакцин, содержащие мутированный белок, связывающий фактор н
TWI355390B (en) Immunogenic peptide carrier conjugates and methods
CN110612118B (zh) 用于引起针对hbv的免疫应答的病毒样粒子
JP2013542224A5 (https=)
HU229968B1 (hu) Sztreptokokkusz oltóanyag
JP6909728B2 (ja) 弱毒化細菌によって送達されるリコール抗原を使用する癌の治療
TW202038996A (zh) 包含肺炎鏈球菌多醣-蛋白質共軛物之組合物及其使用方法
NO20076239L (no) Peptidkonjugatpreparater og fremgangsmater for forebygging og behandling av Alzheimers sykdom
ES2257769T3 (es) Metodo para la preparacion de vacunas multivalentes.
JP2010500399A5 (https=)
CN101421299A (zh) 用于诱导产生抗淀粉样β肽抗体的肽疫苗
US20150258190A1 (en) Nicotinamide as adjuvant
JP2014508734A5 (https=)
TW201440786A (zh) 無細胞百日咳疫苗
JP2019195328A (ja) デングウイルスワクチンのための方法および組成物
JP2009539821A (ja) ワクチンの舌下投与用医薬組成物、その調製方法およびその使用
JP7396569B2 (ja) Cra4S1遺伝子及びそれによってコードされるタンパク質と応用
JP2020536925A5 (https=)
Chavda et al. History of vaccination
US10933126B2 (en) Clostridium difficile immunogenic compositions and methods of use
WO2004028549A1 (en) A coixenolide capsules for treating prostate disease
US12097254B2 (en) Rabies composition comprising PIKA adjuvant
WO2000012718A1 (en) Superoxide dismutase as a vaccine antigen
JP2013090574A (ja) ペプチドワクチン